Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Reset all filters
01 1ADMELOG SOLOSTAR
02 1BASAGLAR
03 1HUMULIN R
04 1HUMULIN R KWIKPEN
05 1LEVEMIR
06 1LEVEMIR FLEXPEN
07 1LEVEMIR FLEXTOUCH
08 1LEVEMIR INNOLET
09 1LEVEMIR PENFILL
10 1NOVOLOG
11 1NOVOLOG FLEXPEN
12 1NOVOLOG FLEXTOUCH
13 1NOVOLOG INNOLET
14 1NOVOLOG MIX 70/30
15 1NOVOLOG MIX 70/30 FLEXPEN
16 1NOVOLOG MIX 70/30 PENFILL
17 1NOVOLOG PENFILL
18 1TRESIBA
19 1XULTOPHY 100/3.6
Reset all filters
01 218780
02 520986
03 321172
04 521536
05 1203314
06 1205692
07 1208583
08 1209196
Reset all filters
01 19No


Drug : ADMELOG SOLOSTAR
Dosage Form : SOLUTION; SUBCUTANEOUS
Application Number : 209196
Country : US
Patented : No
Drug : NOVOLOG PENFILL
Dosage Form : INJECTABLE; SUBCUTANEOUS
Application Number : 20986
Country : US
Patented : No

Drug : NOVOLOG INNOLET
Dosage Form : INJECTABLE; SUBCUTANEOUS
Application Number : 20986
Country : US
Patented : No

Drug : NOVOLOG FLEXPEN
Dosage Form : INJECTABLE; SUBCUTANEOUS
Application Number : 20986
Country : US
Patented : No

Drug : NOVOLOG
Dosage Form : INJECTABLE; SUBCUTANEOUS
Application Number : 20986
Country : US
Patented : No

Drug : LEVEMIR
Dosage Form : INJECTABLE; SUBCUTANEOUS
Application Number : 21536
Country : US
Patented : No

INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Drug : NOVOLOG MIX 70/30 PENFILL
Dosage Form : INJECTABLE; SUBCUTANEOUS
Application Number : 21172
Country : US
Patented : No

INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Drug : NOVOLOG MIX 70/30 FLEXPEN
Dosage Form : INJECTABLE; SUBCUTANEOUS
Application Number : 21172
Country : US
Patented : No

INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Drug : NOVOLOG MIX 70/30
Dosage Form : INJECTABLE; SUBCUTANEOUS
Application Number : 21172
Country : US
Patented : No

Drug : NOVOLOG FLEXTOUCH
Dosage Form : INJECTABLE; SUBCUTANEOUS
Application Number : 20986
Country : US
Patented : No



